BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6851172)

  • 1. Assessment of liver function using fasting bile salt concentrations in psoriasis prior to and during methotrexate therapy.
    Lawrence CM; Strange RC; Summerly R; Scriven AJ; Elmahallawy M; Wood A; Fletcher PJ; Beckett GJ
    Clin Chim Acta; 1983 Apr; 129(3):341-51. PubMed ID: 6851172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatotoxicity of methotrexate in the treatment of psoriasis.
    Palmer HM
    Practitioner; 1973 Sep; 211(263):324-8. PubMed ID: 4759241
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical value of bile salt tests in anicteric liver disease.
    Douglas JG; Beckett GJ; Nimmo IA; Finlayson ND; Percy-Robb IW
    Gut; 1981 Feb; 22(2):141-8. PubMed ID: 7215945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver biopsies upsilon liver scans in methotrexate-treated patients with psoriasis.
    Geronemus RG; Auerbach R; Tobias H
    Arch Dermatol; 1982 Sep; 118(9):649-51. PubMed ID: 7114866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in liver histology during methotrexate therapy of psoriasis correlated to the concentration of methotrexate and folate in erythrocytes.
    Hendel J; Poulsen H; Nyfors B; Nyfors A
    Acta Pharmacol Toxicol (Copenh); 1985 Apr; 56(4):321-6. PubMed ID: 4024960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound as a screening procedure for methotrexate-induced hepatic damage in severe psoriasis.
    Miller JA; Dodd H; Rustin MH; Lees WR; Levene GM; Kirby JD; Munro DD
    Br J Dermatol; 1985 Dec; 113(6):699-705. PubMed ID: 3913457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity of long-term methotrexate therapy for psoriasis.
    Tobias H; Auerbach R
    Arch Intern Med; 1973 Sep; 132(3):391-6. PubMed ID: 4783020
    [No Abstract]   [Full Text] [Related]  

  • 8. [Liver biopsy studies in long-term therapy of psoriasis using methotrexate].
    Dietz O; Pachaly A; Schillat I
    Dermatol Monatsschr; 1974 Aug; 160(8):634-42. PubMed ID: 4216519
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma bile salt levels in patients presenting with generalised pruritus: an improved indicator of occult liver disease.
    Lawrence CM; Strange RC; Scriven AJ; Wood A; Beckett GJ
    Ann Clin Biochem; 1985 May; 22 ( Pt 3)():232-5. PubMed ID: 4026184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver disease in psoriatics--An effect of methotrexate therapy?
    Shapiro HA; Trowbridge JO; Lee JC; Maibach HI
    Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of antipyrine clearance to measure liver damage in psoriatic patients receiving methotrexate.
    Paramsothy J; Strange R; Sharif H; Collins M; Shaw P; Lawrence CM
    Br J Dermatol; 1988 Dec; 119(6):761-5. PubMed ID: 3203069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate maintenance therapy and liver damage in psoriasis.
    van de Kerkhof PC; Hoefnagels WH; van Haelst UJ; Mali JW
    Clin Exp Dermatol; 1985 May; 10(3):194-200. PubMed ID: 4006282
    [No Abstract]   [Full Text] [Related]  

  • 13. [Liver damage in methotrexate-treated patients. When liver biopsy is necessary in the follow-up?].
    Nieminen U; Höök-Nikanne J; Kärkkäinen P; Niemelä S
    Duodecim; 2005; 121(24):2680-8. PubMed ID: 16454249
    [No Abstract]   [Full Text] [Related]  

  • 14. The aminopyrine breath test, an inadequate early indicator of methotrexate-induced liver disease in patients with psoriasis.
    Williams CN; McCauley D; Malatjalian DA; Turnbull GK; Ross JB
    Clin Invest Med; 1987 Mar; 10(2):54-8. PubMed ID: 3581546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raised serum bile acid concentrations after occupational exposure to styrene: a possible sign of hepatotoxicity?
    Edling C; Tagesson C
    Br J Ind Med; 1984 May; 41(2):257-9. PubMed ID: 6722052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver biopsies in psoriatics--complications and evaluation.
    Creswell SN; Burrows D
    Int J Dermatol; 1980 May; 19(4):217-9. PubMed ID: 7399795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are serum bile salt concentrations raised in hyperlipidaemia?
    Beckett GJ; Douglas JG; Finlayson ND; Percy-Robb IW
    Gut; 1980 Mar; 21(3):219-22. PubMed ID: 7399323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of serum bile acids in the identification of vinyl chloride hepatotoxicity.
    Liss GM; Greenberg RA; Tamburro CH
    Am J Med; 1985 Jan; 78(1):68-76. PubMed ID: 3966491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis.
    Beck HI; Foged EK
    Dermatologica; 1983; 167(2):94-6. PubMed ID: 6628806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.